Introducing Dendritic Cell Antibody Internalization as an Immunogenicity Risk Assessment Tool
- 20 May 2022
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 14 (10) , 703-713
Abstract
Aim: Immunogenicity risk assessment assays are powerful tools that assess the relative immunogenicity of potential biotherapeutics. We detail here the development of a novel assay that measures the...Keywords
This publication has 23 references indexed in Scilit:
- Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibodyClinical and Experimental Immunology, 2015
- The ins and outs of MHC class II-mediated antigen processing and presentationNature Reviews Immunology, 2015
- The generation of antibody-secreting plasma cellsNature Reviews Immunology, 2015
- The function of Fcγ receptors in dendritic cells and macrophagesNature Reviews Immunology, 2014
- T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigationClinical Immunology, 2013
- Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activitiesmAbs, 2012
- HLA-DR-presented Peptide Repertoires Derived From Human Monocyte-derived Dendritic Cells Pulsed With Blood Coagulation Factor VIIIMolecular & Cellular Proteomics, 2011
- Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeuticsClinical Immunology, 2010
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.Journal of Experimental Medicine, 1995
- Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages.Journal of Experimental Medicine, 1989